
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1049 | 1092 | 1210 | 1501 | 1664 |
Fund Return | 8.1% | 4.87% | 9.16% | 6.55% | 8.46% | 5.22% |
Place in category | 147 | 231 | 410 | 151 | 249 | 177 |
% in Category | 17 | 29 | 60 | 25 | 44 | 48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TIAA-CREF Equity Index Instl | 16.52B | 1.17 | 11.54 | 12.33 | ||
TIAA-CREF International Eq Idx Inst | 16.03B | 8.14 | 6.82 | 5.49 | ||
TIAA-CREF Large-Cap Gr Idx Instl | 13.05B | -1.69 | 14.78 | 15.94 | ||
TIAA-CREF Large-Cap Value Idx Inst | 9.12B | 5.04 | 8.62 | 8.91 | ||
TIAA-CREF S&P 500 Index Instl | 7.12B | 1.44 | 12.50 | 12.92 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 209.79B | 5.17 | 4.34 | 4.95 | ||
Vanguard Total Intl Stock Index Adm | 76.18B | 5.24 | 4.42 | 5.02 | ||
Fidelity International Index Inst | 56.32B | 8.06 | 6.85 | 5.50 | ||
Fidelity Series Global ex US Index | 52.22B | 6.06 | 4.88 | 4.92 | ||
Strategic Advisers International I | 45.83B | 7.61 | 6.47 | 6.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Msci Eafe Mar25 Ifus 20250321 | - | 2.13 | - | - | |
ASML Holding | NL0010273215 | 1.67 | 578.70 | -6.10% | |
SAP | DE0007164600 | 1.63 | 238.950 | -4.07% | |
Novo Nordisk B | DK0062498333 | 1.54 | 456.9 | -2.10% | |
Nestle | CH0038863350 | 1.26 | 90.66 | +0.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review